Journals / Osmangazi Tıp Dergisi / 2026 / Cilt: 48 Sayı: 1

Disease Overshadowed by Asthma and Thromboembolism: Hypereosinophilic Syndrome

Tuğçe Karamustafalıoğlu(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0009-0003-6316-4336
Eylem Sercan Özgür(MERSİN ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-4459-232X
Pages
141–144
Publication Date
2025-12-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Cases encountered in clinical practice do not always exhibit the classic presentations described in the literature; therefore, assessing each patient within their unique context through a holistic approach is essential for achieving accurate diagnosis and appropriate management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypereosinophilic syndrome is a rare condition characterized by persistent eosinophilia and multisystem involvement.
📊
Key Findings & Data:In our case, we present the diagnostic course of a patient with a 10-year history of asthma and two episodes of presumed idiopathic pulmonary thromboembolism within the past two years, who developed new bilateral pulmonary consolidations and a morphea-like skin lesion.
💡
Conclusion & Impact:Cases encountered in clinical practice do not always exhibit the classic presentations described in the literature; therefore, assessing each patient within their unique context through a holistic approach is essential for achieving accurate diagnosis and appropriate management.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:hipereozinofili · pnömoni · astım

Abstract

Hypereosinophilic syndrome is a rare condition characterized by persistent eosinophilia and multisystem involvement. Diagnosis is established after excluding secondary causes, and it can easily be overlooked when clinical features overlap with other diseases. Consequently, the diagnostic process becomes more challenging in patients with coexisting chronic respiratory disorders and a history of thromboembolic events. In our case, we present the diagnostic course of a patient with a 10-year history of asthma and two episodes of presumed idiopathic pulmonary thromboembolism within the past two years, who developed new bilateral pulmonary consolidations and a morphea-like skin lesion. Cases encountered in clinical practice do not always exhibit the classic presentations described in the literature; therefore, assessing each patient within their unique context through a holistic approach is essential for achieving accurate diagnosis and appropriate management.

Özet

Hipereozinofilik sendrom, kalıcı eozinofili ve çoklu organ tutulumu ile seyreden, nadir görülen bir hastalıktır. Tanı, sekonder nedenlerin dışlanması ile konur ve klinik belirtiler başka hastalıklarla örtüştüğünde kolayca gözden kaçabilir. Bu nedenle, özellikle eşlik eden kronik solunum hastalıkları ve tromboembolik öyküsü olan olgularda tanı güçleşir. Olgumuzda, 10 yıldır astım tanısı ile izlenen ve son iki yılda iki kez idiopatik olduğu düşünülen pulmoner tromboemboli geçiren bir hastada, yeni gelişen bilateral akciğer infiltratları ve ciltte morfea benzeri lezyon ile ortaya çıkan tanı süreci aktarılmıştır. Klinik pratiğe yansıyan vakalar, her zaman literatürde tarif edilen klasik görünümleri sergilemeyebilir; bu nedenle her hastayı kendi bağlamında bütüncül bir yaklaşımla değerlendirmek, doğru tanı ve tedaviye ulaşmada kritik öneme sahiptir.

🔖

Cite This Article

Karamustafalıoğlu, T., Özgür, E. S. (2025). Disease Overshadowed by Asthma and Thromboembolism: Hypereosinophilic Syndrome. Osmangazi Tıp Dergisi, Cilt: 48 Sayı: 1, 141–144. https://doi.org/10.20515/otd.1667999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Curtis C, Ogbogu P. Hypereosinophilic Syndrome. Clin Rev Allergy Immunol. 2016;50(2):240-51.
  2. Tosca MA, Trincianti C, Naso M, Nosratian V, Ciprandi G. Treatment of Allergic Rhinitis in Clinical Practice. Curr Pediatr Rev. 2024;20(3):271-7.
  3. Noh HR, Magpantay GG. Hypereosinophilic syndrome. Allergy Asthma Proc. 2017;38(1):78-81.
  4. Timuçin Çİ L, Orhan A, Dede Şİ T, Ekrem MÜ F. Churg Strauss sendromu ve ayırıcı tanısı: İki olgu sunumu. Uluslararası Hematoloji-Onkoloji Dergisi. 2007;17(4):228-32.
  5. Mikhail ES, Ghatol A. Hypereosinophilic Syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing
  6. Copyright © 2025, StatPearls Publishing LLC.; 2025.
  7. Liu Y, Meng X, Feng J, Zhou X, Zhu H. Hypereosinophilia with Concurrent Venous Thromboembolism: Clinical Features, Potential Risk Factors, and Short-term Outcomes in a Chinese Cohort. Scientific Reports. 2020;10(1):8359.
  8. Nagira D, Miyamoto S, Mizukoshi T, Yanagisawa A, Funauchi A, Kanaoka K, et al. Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case report. Allergy, Asthma & Clinical Immunology. 2025;21(1):23.
  9. Khoury P, Akuthota P, Kwon N, Steinfeld J, Roufosse F. HES and EGPA: Two Sides of the Same Coin. Mayo Clinic Proceedings. 2023;98(7):1054-70.
  10. Caminati M, Brussino L, Carlucci M, Carlucci P, Carpagnano LF, Caruso C, et al. Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC). Cells. 2024;13(14):1180.